Aclaris Therapeutics Stock Quote ACRS - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

1.29

Bid

1.20

Ask

1.32

Volume

5,786

0.00 Day's Range 0.00

0.5902 52 Week Range 11.12

Market Cap

82.982M

Previous Close

1.17

Open

Last Trade

1.3

Last Trade Time

05:17:38

Financial Volume

VWAP

Average Volume (3m)

1,089,978

Shares Outstanding

70,925,042

Dividend Yield

PE Ratio

-0.94

Earnings Per Share (EPS)

-1.25

Revenue

31.25M

Net Profit

-88.48M

Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from... Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; and ATI-1777. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aclaristx.com

Headquarters

Wilmington, Delaware, USA

Founded

1970

Aclaris Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ACRS. The last closing price for Aclaris Therapeutics was $1.17. Over the last year, Aclaris Therapeutics shares have traded in a share price range of $ 0.5902 to $ 11.12.

Aclaris Therapeutics currently has 70,925,042 shares outstanding. The market capitalization of Aclaris Therapeutics is $82.98 million. Aclaris Therapeutics has a price to earnings ratio (PE ratio) of -0.94.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.07	5.73770491803	1.22	1.26	1.14	793175	1.2112699	CS
4	0.03	2.38095238095	1.26	1.32	1.14	678670	1.21582369	CS
12	0.11	9.32203389831	1.18	1.51	1.05	1089978	1.20838409	CS
26	-3.68	-74.0442655936	4.97	5.705	0.5902	3096717	1.09795814	CS
52	-7.76	-85.7458563536	9.05	11.12	0.5902	1924300	2.45878706	CS
156	-24.49	-94.996121024	25.78	26.5	0.5902	999069	6.83244614	CS
260	-5.09	-79.7805642633	6.38	30.375	0.5902	1025492	7.48197526	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ILAGIntelligent Living Application Group Inc	$ 0.8499 (57.39%)	2.46M
AIREreAlpha Tech Corporation	$ 1.59 (37.07%)	1.25M
CDTXCidara Therapeutics Inc	$ 16.16 (31.49%)	15.15k
MRINMarin Software Incorporated	$ 2.95 (25.00%)	15
CULLCullman Bancorp Inc	$ 12.49 (20.27%)	21
ZAPPZapp Electric Vehicles Group Ltd	$ 2.67 (-31.71%)	529
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.3039 (-28.54%)	537.18k
FBLGraniteShares ETF Trust GraniteShares	$ 19.83 (-25.92%)	70.72k
BPTSBiophytis SA	$ 8.00 (-17.55%)	622
AGBAAGBA Group Holding Ltd	$ 2.09 (-14.69%)	264.28k
SBFMSunshine Biopharma Inc	$ 1.04 (11.83%)	3.04M
ILAGIntelligent Living Application Group Inc	$ 0.8499 (57.39%)	2.46M
AIREreAlpha Tech Corporation	$ 1.59 (37.07%)	1.25M
NUWENewellis Inc	$ 0.30 (19.00%)	1.23M
SQQQProShares UltraPro Short QQQ	$ 12.12 (2.62%)	1.11M